Company / Current Liabilities per Share
Vir Biotechnology, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.68
FY2025
5-year range
$0.68 / $3.90
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#137 of 210
Health Care
What the data says
At $0.68, Vir Biotechnology, Inc.'s current liabilities per share ranks #74 of 210 in the Health Care sector. Current Liabilities per Share has declined for 3 consecutive years, from $3.90 in FY2022 to $0.68 in FY2025.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -5.9%.
Improved from $1.32 to $0.68 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -44.2%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
#74 of 210 in Health CareTop 35% of 210This company $0.68 Sector average $23.79
▼
-97.2% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 23.7% year-over-year.
- Ranks #137 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | -23.7% |
| FY2024 | $0.89 | -32.6% |
| FY2023 | $1.32 | -66.2% |
| FY2022 | $3.90 | +45.5% |
| FY2021 | $2.68 | +191.0% |
| FY2020 | $0.92 | -86.2% |
| FY2019 | $6.68 | +28.4% |
| FY2018 | $5.21 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026